On March 16, 2026, Judge Michael B. Kaplan of the U.S. Bankruptcy Court for the District of New Jersey issued a closely watched letter opinion denying motions by the U.S. Trustee and an ad hoc cross‑holder group to dismiss or
In Solvency
Understandable Insights from Fox Rothschild's National Bankruptcy Practice
In Solvency, published by Fox Rothschild LLP, focuses on legal issues surrounding insolvency and bankruptcy, particularly in the healthcare sector. The blog covers topics such as Chapter 11 reorganization plans, third-party releases in bankruptcy cases, and the impact of government healthcare funding cuts on financially distressed providers. It analyzes significant court decisions, including Supreme Court rulings affecting bankruptcy law, and explores how these decisions influence bankruptcy proceedings and creditor rights. The blog also discusses procedural updates in bankruptcy courts, with a focus on jurisdictions like New Jersey, and addresses the financial challenges faced by healthcare institutions amid regulatory and policy changes.
Blog Authors
Latest from In Solvency
Supreme Court Puts a Clock on Attacking “Void” Judgments
The U.S. Supreme Court has clarified that there is a time limit—specifically, a “reasonable time” under Rule 60(c)(1)—for filing motions to set aside judgments as “void” under Rule 60(b)(4), even where the alleged voidness stems from lack of proper service…
New Jersey Bankruptcy Judge Michael Kaplan on Bankruptcy Practice – Pragmatism, Feasibility, and the Realities of Chapter 11
In Episode 22 of The Octus Download (available on Apple Podcasts, Spotify, Amazon Music), hosts Jason Sanjana and Kevin Eckhardt interviewed the Honorable Michael B. Kaplan, U.S. Bankruptcy Judge for the District of New Jersey, who…
Christmas Tree Shops: Unwrapping the Delaware Court’s Gift for Pleading the Preference Due Diligence Requirement
Defining the Boundaries of Consensual Third-Party Releases – Tehum/YesCare Case Study
In 2024, the Supreme Court, in Harrington v. Purdue Pharma L.P., 603 U.S. 204 (2024), held that the Bankruptcy Code does not authorize nonconsensual third-party releases in Chapter 11 reorganization plans, meaning affected creditors cannot be forced to release claims…
Trump Administration’s Proposed Health Care Cuts Pose Risks to Distressed Providers
New Jersey Bankruptcy Courts Remain a Strong Option for Debtors Seeking to Obtain a Third-Party Release in a post-Purdue Pharma World Following the BowFlex Decision
The restructuring industry held its proverbial breath following the Supreme Court’s decision in Harrington v. Purdue Pharma L.P., which invalidated the nonconsensual third-party release in the debtors’ plan. While various courts continue to interpret the Purdue Pharma decision, New Jersey…
The Impact of Purdue Pharma
It has been approximately two months since the highly anticipated Supreme Court decision in Harrington v. Purdue Pharma L.P., and it is already making a significant impact in bankruptcies around the country.
In September 2019, Purdue Pharma L.P. and 23…
New Jersey Releases New Chapter 11 Complex Procedures and Other Rule Updates
Pursuant to the New Jersey Bankruptcy Court’s (the “Court”) annual rule making cycle, the Court implemented various changes to the New Jersey Local Rules and Local Forms, which became effective on August 1, 2024.[1]
Of particular…
The Circuit City Landmine Redux, the Final Word (Office of the United States Trustee v. John Q. Hammons Fall 2006, LLC): Supreme Court Holds that Chapter 11 Debtors Do Not Get a Refund on U.S. Trustee Quarterly Fees Under Unconstitutional Fee Increase
As previously discussed and anticipated in prior blog posts,[1] the United States Supreme Court’s decision in Siegel v. Fitzgerald, 596 U.S. 464, 142 S.Ct. 1770, 213 L.Ed.2d 39 (2022), which struck down as unconstitutional the United States Trustee System…

